Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions
http://ghr.nlm.nih.gov/     A service of the U.S. National Library of Medicine®

Chromosome 1

Reviewed October 2012

What is chromosome 1?

Humans normally have 46 chromosomes in each cell, divided into 23 pairs. Two copies of chromosome 1, one copy inherited from each parent, form one of the pairs. Chromosome 1 is the largest human chromosome, spanning about 249 million DNA building blocks (base pairs) and representing approximately 8 percent of the total DNA in cells.

Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 1 likely contains 2,000 to 2,100 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body.

Genes on chromosome 1 are among the estimated 20,000 to 25,000 total genes in the human genome.

Genetics Home Reference includes these genes on chromosome 1:

  • ABCA4
  • ACADM
  • ACTA1
  • AGL
  • AGT
  • ALDH4A1
  • ALG6
  • ALPL
  • ALX3
  • AMPD1
  • ARID1A
  • ASPM
  • ATP1A2
  • BSND
  • CACNA1S
  • CASQ2
  • CDC73
  • CFH
  • CFHR5
  • CHRNB2
  • CLCNKA
  • CLCNKB
  • COL8A2
  • COL9A2
  • COL11A1
  • CPT2
  • CRB1
  • DARS2
  • DBT
  • DIRAS3
  • DPYD
  • EDARADD
  • EGLN1
  • EIF2B3
  • ESPN
  • F5
  • FH
  • FMO3
  • FUCA1
  • GALE
  • GBA
  • GJB3
  • GJB4
  • GNAI3
  • GNAT2
  • GNPAT
  • HAX1
  • HFE2
  • HMGCL
  • HSD3B2
  • IL23R
  • IRF6
  • KCNQ4
  • KIF1B
  • LAMB3
  • LAMC2
  • LBR
  • LDLRAP1
  • LEPR
  • LEPRE1
  • LMNA
  • LOR
  • LYST
  • MFN2
  • MPL
  • MPZ
  • MTHFR
  • MTR
  • MUC1
  • MUTYH
  • MYOC
  • NCF2
  • NCSTN
  • NGF
  • NLRP3
  • NOTCH2
  • NRAS
  • NTRK1
  • ORC1
  • PARK7
  • PCSK9
  • PHGDH
  • PIGV
  • PIK3CD
  • PINK1
  • PKLR
  • PLOD1
  • PPOX
  • PPT1
  • PSEN2
  • PTPN22
  • RBM8A
  • REN
  • RPE65
  • RPL5
  • RPL11
  • RYR2
  • SDHB
  • SDHC
  • SEPN1
  • SERPINC1
  • SKI
  • SLC2A1
  • SLC19A2
  • SLC30A10
  • TARDBP
  • TGFB2
  • TNNT2
  • TPM3
  • TSHB
  • UROD
  • USH2A
  • WNT4
  • YARS
  • ZMPSTE24

How are changes in chromosome 1 related to health conditions?

Many genetic conditions are related to changes in particular genes on chromosome 1. This list of disorders associated with genes on chromosome 1 provides links to additional information.

Genetics Home Reference includes these conditions related to genes on chromosome 1:

  • actin-accumulation myopathy
  • activated PI3K-delta syndrome
  • adenosine monophosphate deaminase deficiency
  • age-related macular degeneration
  • Alagille syndrome
  • alternating hemiplegia of childhood
  • Alzheimer disease
  • amyotrophic lateral sclerosis
  • anencephaly
  • ankylosing spondylitis
  • arrhythmogenic right ventricular cardiomyopathy
  • atypical hemolytic-uremic syndrome
  • auriculo-condylar syndrome
  • autoimmune Addison disease
  • autoimmune lymphoproliferative syndrome
  • autosomal dominant nocturnal frontal lobe epilepsy
  • autosomal recessive primary microcephaly
  • Bartter syndrome
  • 3-beta-hydroxysteroid dehydrogenase deficiency
  • breast cancer
  • cap myopathy
  • carnitine palmitoyltransferase II deficiency
  • catecholaminergic polymorphic ventricular tachycardia
  • Charcot-Marie-Tooth disease
  • Chediak-Higashi syndrome
  • chronic granulomatous disease
  • Coffin-Siris syndrome
  • color vision deficiency
  • congenital disorder of glycosylation type Ic
  • congenital fiber-type disproportion
  • congenital hypothyroidism
  • congenital insensitivity to pain with anhidrosis
  • core binding factor acute myeloid leukemia
  • Cowden syndrome
  • Crohn disease
  • cytogenetically normal acute myeloid leukemia
  • dense deposit disease
  • Diamond-Blackfan anemia
  • dihydropyrimidine dehydrogenase deficiency
  • early-onset glaucoma
  • Ehlers-Danlos syndrome
  • Emery-Dreifuss muscular dystrophy
  • erythrokeratodermia variabilis et progressiva
  • essential thrombocythemia
  • factor V deficiency
  • factor V Leiden thrombophilia
  • familial adenomatous polyposis
  • familial cold autoinflammatory syndrome
  • familial dilated cardiomyopathy
  • familial erythrocytosis
  • familial hemiplegic migraine
  • familial hypertrophic cardiomyopathy
  • familial hypobetalipoproteinemia
  • familial isolated hyperparathyroidism
  • familial restrictive cardiomyopathy
  • frontonasal dysplasia
  • Fuchs endothelial dystrophy
  • fucosidosis
  • fumarase deficiency
  • galactosemia
  • gastrointestinal stromal tumor
  • Gaucher disease
  • Gitelman syndrome
  • GLUT1 deficiency syndrome
  • glycogen storage disease type III
  • Graves disease
  • Greenberg dysplasia
  • hemochromatosis
  • hereditary antithrombin deficiency
  • hereditary leiomyomatosis and renal cell cancer
  • hereditary paraganglioma-pheochromocytoma
  • hereditary sensory and autonomic neuropathy type V
  • hidradenitis suppurativa
  • homocystinuria
  • Hutchinson-Gilford progeria syndrome
  • 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
  • hypercholesterolemia
  • hypermanganesemia with dystonia, polycythemia, and cirrhosis
  • hyperparathyroidism-jaw tumor syndrome
  • hyperprolinemia
  • hypohidrotic ectodermal dysplasia
  • hypokalemic periodic paralysis
  • hypophosphatasia
  • idiopathic inflammatory myopathy
  • infantile neuronal ceroid lipofuscinosis
  • intranuclear rod myopathy
  • junctional epidermolysis bullosa
  • juvenile Batten disease
  • juvenile idiopathic arthritis
  • Kufs disease
  • late-infantile neuronal ceroid lipofuscinosis
  • Leber congenital amaurosis
  • leptin receptor deficiency
  • leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
  • leukoencephalopathy with vanishing white matter
  • limb-girdle muscular dystrophy
  • Loeys-Dietz syndrome
  • Mabry syndrome
  • malignant hyperthermia
  • mandibuloacral dysplasia
  • maple syrup urine disease
  • medium-chain acyl-CoA dehydrogenase deficiency
  • medullary cystic kidney disease type 1
  • Meier-Gorlin syndrome
  • Muckle-Wells syndrome
  • Müllerian aplasia and hyperandrogenism
  • multiminicore disease
  • multiple epiphyseal dysplasia
  • nemaline myopathy
  • neonatal onset multisystem inflammatory disease
  • neuroblastoma
  • nonsyndromic deafness
  • nonsyndromic paraganglioma
  • Noonan syndrome
  • osteogenesis imperfecta
  • Parkinson disease
  • phosphoglycerate dehydrogenase deficiency
  • popliteal pterygium syndrome
  • porphyria
  • primary myelofibrosis
  • psoriatic arthritis
  • pyruvate kinase deficiency
  • renal tubular dysgenesis
  • REN-related kidney disease
  • retinitis pigmentosa
  • rheumatoid arthritis
  • rhizomelic chondrodysplasia punctata
  • severe congenital neutropenia
  • Shprintzen-Goldberg syndrome
  • spina bifida
  • sporadic hemiplegic migraine
  • Stargardt macular degeneration
  • Stickler syndrome
  • systemic lupus erythematosus
  • systemic scleroderma
  • thiamine-responsive megaloblastic anemia syndrome
  • thrombocytopenia-absent radius syndrome
  • trimethylaminuria
  • type 1 diabetes
  • Usher syndrome
  • van der Woude syndrome
  • vitiligo
  • Vohwinkel syndrome

Changes in the structure or number of copies of a chromosome can also cause problems with health and development. The following chromosomal conditions are associated with such changes in chromosome 1.

1p36 deletion syndrome

1p36 deletion syndrome is caused by a deletion of genetic material from a specific region in the short (p) arm of chromosome 1. The signs and symptoms of this disorder, which include intellectual disability, distinctive facial features, and structural abnormalities in several body systems, are probably related to the loss of multiple genes in this region. The size of the deletion varies among affected individuals.

1q21.1 microdeletion

1q21.1 microdeletion is a chromosomal change in which a small piece of the long (q) arm of chromosome 1 is deleted in each cell. Specifically, affected individuals are missing about 1.35 million DNA building blocks (base pairs), also written as 1.35 megabases (Mb), in the q21.1 region. The exact size of the deleted region varies, but it typically contains at least nine genes. The loss of several of these genes probably contributes to the various signs and symptoms that can be associated with a 1q21.1 microdeletion. Related features can include delayed development, intellectual disability, physical abnormalities, and neurological and psychiatric problems; however, some individuals with a 1q21.1 microdeletion have no obvious signs or symptoms.

neuroblastoma

Deletions within region 1p36 have also been associated with another condition called neuroblastoma. Neuroblastoma is a type of cancerous tumor composed of immature nerve cells (neuroblasts). These deletions are somatic mutations, which means they occur during a person's lifetime and are present only in the cells that become cancerous. About 25 percent of people with neuroblastoma have a deletion of 1p36.1-1p36.3, which is associated with a more severe form of neuroblastoma. Researchers believe the deleted region could contain a gene that keeps cells from growing and dividing too quickly or in an uncontrolled way, called a tumor suppressor gene. When tumor suppressor genes are deleted, cancer can occur. Researchers have identified several possible tumor suppressor genes in the deleted region of chromosome 1, and more research is needed to understand what role these genes play in neuroblastoma development.

thrombocytopenia-absent radius syndrome

A deletion in the 1q21.1 region of chromosome 1 is involved in most cases of thrombocytopenia-absent radius (TAR) syndrome. TAR syndrome is characterized by the absence of a bone called the radius in each forearm and a shortage (deficiency) of blood cells involved in clotting (platelets).

The deletion in chromosome 1 involved in TAR syndrome eliminates at least 200,000 DNA building blocks (200 kilobases, or 200 kb) from the long (q) arm of the chromosome, including a gene called RBM8A. Most people with TAR syndrome have the deletion in one copy of chromosome 1, which removes one copy of the RBM8A gene, and a mutation in the other copy of the RBM8A gene in each cell. The RBM8A gene provides instructions for making a protein called RNA-binding motif protein 8A. This protein is believed to be involved in a number of important cellular functions involving the production of other proteins.

RBM8A gene mutations that cause TAR syndrome reduce the amount of RNA-binding motif protein 8A in cells. The deletion on chromosome 1 eliminates one copy of the RBM8A gene in each cell and the RNA-binding motif protein 8A that would have been produced from it. The reduced total amount of RNA-binding motif protein 8A is thought to cause problems in the development of certain tissues, but it is unknown how it causes the specific signs and symptoms of TAR syndrome. No cases have been reported in which individuals have deletions on both copies of chromosome 1 that include both copies of the RBM8A gene; studies indicate that the complete loss of RNA-binding motif protein 8A is not compatible with life.

Researchers sometimes refer to the deletion in chromosome 1 associated with TAR syndrome as the 200-kb deletion to distinguish it from another chromosomal abnormality called a 1q21.1 microdeletion. People with a 1q21.1 microdeletion are missing a different, larger DNA segment in the chromosome 1q21.1 region near the area where the 200-kb deletion occurs. The chromosomal change related to 1q21.1 microdeletion is often called the recurrent distal 1.35-Mb deletion.

other cancers

Changes in the structure of chromosome 1 are associated with other forms of cancer and conditions related to cancer. These changes are typically somatic, which means they are acquired during a person's lifetime and are present only in tumor cells.

Deletions in the short (p) arm of the chromosome have been identified in tumors of the brain and kidney. Duplications in the long (q) arm of the chromosome have been reported in a disorder called myelodysplastic syndrome, which is a disease of the blood and bone marrow. People with this condition have a low number of red blood cells (anemia) and an increased risk of developing leukemia.

other chromosomal conditions

Other changes in the number or structure of chromosome 1 can have a variety of effects, including delayed growth and development, distinctive facial features, birth defects, and other health problems. Changes to chromosome 1 may include an extra segment of the short (p) or long (q) arm of the chromosome in each cell (partial trisomy 1p or 1q), a missing segment of the short or long arm of the chromosome in each cell (partial monosomy 1p or 1q), or a circular structure called ring chromosome 1. Ring chromosomes occur when a chromosome breaks in two places and the ends of the chromosome arms fuse together to form a circular structure.

Is there a standard way to diagram chromosome 1?

Geneticists use diagrams called ideograms as a standard representation for chromosomes. Ideograms show a chromosome's relative size and its banding pattern. A banding pattern is the characteristic pattern of dark and light bands that appears when a chromosome is stained with a chemical solution and then viewed under a microscope. These bands are used to describe the location of genes on each chromosome.

Ideogram of chromosome 1
See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.

Where can I find additional information about chromosome 1?

You may find the following resources about chromosome 1 helpful. These materials are written for the general public.

You may also be interested in these resources, which are designed for genetics professionals and researchers.

What glossary definitions help with understanding chromosome 1?

anemia ; bone marrow ; cancer ; cell ; chromosome ; clotting ; deficiency ; deletion ; disability ; distal ; DNA ; gene ; inherited ; kb ; kidney ; leukemia ; Mb ; monosomy ; motif ; mutation ; myelodysplastic syndrome ; neuroblasts ; neurological ; platelets ; protein ; ring chromosomes ; RNA ; syndrome ; thrombocytopenia ; trisomy ; tumor ; tumor suppressor gene

You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://www.ghr.nlm.nih.gov/glossary).

References

  • Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, Jolley JD, Cvejic A, Kostadima M, Bertone P, Breuning MH, Debili N, Deloukas P, Favier R, Fiedler J, Hobbs CM, Huang N, Hurles ME, Kiddle G, Krapels I, Nurden P, Ruivenkamp CA, Sambrook JG, Smith K, Stemple DL, Strauss G, Thys C, van Geet C, Newbury-Ecob R, Ouwehand WH, Ghevaert C. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet. 2012 Feb 26;44(4):435-9, S1-2. doi: 10.1038/ng.1083. (http://www.ncbi.nlm.nih.gov/pubmed/22366785?dopt=Abstract)
  • Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005 Nov 24;353(21):2243-53. (http://www.ncbi.nlm.nih.gov/pubmed/16306521?dopt=Abstract)
  • Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T, Lalani SR, Graham B, Lee B, Shinawi M, Shen J, Kang SH, Pursley A, Lotze T, Kennedy G, Lansky-Shafer S, Weaver C, Roeder ER, Grebe TA, Arnold GL, Hutchison T, Reimschisel T, Amato S, Geragthy MT, Innis JW, Obersztyn E, Nowakowska B, Rosengren SS, Bader PI, Grange DK, Naqvi S, Garnica AD, Bernes SM, Fong CT, Summers A, Walters WD, Lupski JR, Stankiewicz P, Cheung SW, Patel A. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008 Dec;40(12):1466-71. doi: 10.1038/ng.279. (http://www.ncbi.nlm.nih.gov/pubmed/19029900?dopt=Abstract)
  • Chang H, Qi X, Yeung J, Reece D, Xu W, Patterson B. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia. Leuk Res. 2009 Feb;33(2):259-62. doi: 10.1016/j.leukres.2008.06.027. Epub 2008 Aug 3. (http://www.ncbi.nlm.nih.gov/pubmed/18676019?dopt=Abstract)
  • Ensembl Human Map View (http://www.ensembl.org/Homo_sapiens/Location/Chromosome?chr=1;r=1:1-249250621)
  • Gajecka M, Mackay KL, Shaffer LG. Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet. 2007 Nov 15;145C(4):346-56. Review. (http://www.ncbi.nlm.nih.gov/pubmed/17918734?dopt=Abstract)
  • Gene Review: 1p36 Deletion Syndrome (http://www.ncbi.nlm.nih.gov/books/NBK1191/)
  • Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E. The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21. Erratum in: Nature. 2006 Oct 26;443(7114):1013. Banerjee, R [added]; Bryant, SP [added]; Burford, DC [added]; Burrill, WDH [added]; Clegg, SM [added]; Dhami, P [added]; Dovey, O [added]; Faulkner, LM [added]; Gribble, SM [added]; Langford, CF [added]; Pandian, RD [added]; Porter, KM [added]; Prigmore, E [added]. (http://www.ncbi.nlm.nih.gov/pubmed/16710414?dopt=Abstract)
  • Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, Kashork CD, Bacino CA, Shapira SK, Shaffer LG. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet. 2003 May;72(5):1200-12. Epub 2003 Apr 8. (http://www.ncbi.nlm.nih.gov/pubmed/12687501?dopt=Abstract)
  • Ichimura K, Vogazianou AP, Liu L, Pearson DM, Bäcklund LM, Plant K, Baird K, Langford CF, Gregory SG, Collins VP. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene. 2008 Mar 27;27(14):2097-108. Epub 2007 Oct 15. (http://www.ncbi.nlm.nih.gov/pubmed/17934521?dopt=Abstract)
  • Kang SH, Scheffer A, Ou Z, Li J, Scaglia F, Belmont J, Lalani SR, Roeder E, Enciso V, Braddock S, Buchholz J, Vacha S, Chinault AC, Cheung SW, Bacino CA. Identification of proximal 1p36 deletions using array-CGH: a possible new syndrome. Clin Genet. 2007 Oct;72(4):329-38. (http://www.ncbi.nlm.nih.gov/pubmed/17850629?dopt=Abstract)
  • Klopocki E, Schulze H, Strauss G, Ott CE, Hall J, Trotier F, Fleischhauer S, Greenhalgh L, Newbury-Ecob RA, Neumann LM, Habenicht R, König R, Seemanova E, Megarbane A, Ropers HH, Ullmann R, Horn D, Mundlos S. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet. 2007 Feb;80(2):232-40. Epub 2006 Dec 21. (http://www.ncbi.nlm.nih.gov/pubmed/17236129?dopt=Abstract)
  • Kulikowski LD, Bellucco FT, Nogueira SI, Christofolini DM, Smith Mde A, de Mello CB, Brunoni D, Melaragno MI. Pure duplication 1q41-qter: further delineation of trisomy 1q syndromes. Am J Med Genet A. 2008 Oct 15;146A(20):2663-7. doi: 10.1002/ajmg.a.32510. (http://www.ncbi.nlm.nih.gov/pubmed/18798309?dopt=Abstract)
  • Map Viewer: Genes on Sequence (http://www.ncbi.nlm.nih.gov/mapview/maps.cgi?ORG=human&MAPS=ideogr,ugHs,genes&CHR=1)
  • Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, Buysse K, Huang S, Maloney VK, Crolla JA, Baralle D, Collins A, Mercer C, Norga K, de Ravel T, Devriendt K, Bongers EM, de Leeuw N, Reardon W, Gimelli S, Bena F, Hennekam RC, Male A, Gaunt L, Clayton-Smith J, Simonic I, Park SM, Mehta SG, Nik-Zainal S, Woods CG, Firth HV, Parkin G, Fichera M, Reitano S, Lo Giudice M, Li KE, Casuga I, Broomer A, Conrad B, Schwerzmann M, Räber L, Gallati S, Striano P, Coppola A, Tolmie JL, Tobias ES, Lilley C, Armengol L, Spysschaert Y, Verloo P, De Coene A, Goossens L, Mortier G, Speleman F, van Binsbergen E, Nelen MR, Hochstenbach R, Poot M, Gallagher L, Gill M, McClellan J, King MC, Regan R, Skinner C, Stevenson RE, Antonarakis SE, Chen C, Estivill X, Menten B, Gimelli G, Gribble S, Schwartz S, Sutcliffe JS, Walsh T, Knight SJ, Sebat J, Romano C, Schwartz CE, Veltman JA, de Vries BB, Vermeesch JR, Barber JC, Willatt L, Tassabehji M, Eichler EE. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med. 2008 Oct 16;359(16):1685-99. doi: 10.1056/NEJMoa0805384. Epub 2008 Sep 10. (http://www.ncbi.nlm.nih.gov/pubmed/18784092?dopt=Abstract)
  • Millington K, Hudnall SD, Northup J, Panova N, Velagaleti G. Role of chromosome 1 pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: report of 2 new cases. Exp Mol Pathol. 2008 Apr;84(2):189-93. doi: 10.1016/j.yexmp.2007.10.003. Epub 2007 Oct 23. (http://www.ncbi.nlm.nih.gov/pubmed/18339374?dopt=Abstract)
  • Morerio C, Rapella A, Tassano E, Lanino E, Micalizzi C, Rosanda C, Panarello C. Gain of 1q in pediatric myelodysplastic syndromes. Leuk Res. 2006 Nov;30(11):1437-41. Epub 2006 Feb 10. (http://www.ncbi.nlm.nih.gov/pubmed/16472857?dopt=Abstract)
  • Murphy WJ, Frönicke L, O'Brien SJ, Stanyon R. The origin of human chromosome 1 and its homologs in placental mammals. Genome Res. 2003 Aug;13(8):1880-8. Epub 2003 Jul 17. (http://www.ncbi.nlm.nih.gov/pubmed/12869576?dopt=Abstract)
  • Paner GP, Lindgren V, Jacobson K, Harrison K, Cao Y, Campbell SC, Flanigan RC, Picken MM. High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med. 2007 Jan;131(1):81-5. (http://www.ncbi.nlm.nih.gov/pubmed/17227127?dopt=Abstract)
  • Rosenfeld JA, Traylor RN, Schaefer GB, McPherson EW, Ballif BC, Klopocki E, Mundlos S, Shaffer LG, Aylsworth AS; 1q21.1 Study Group. Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes. Eur J Hum Genet. 2012 Jul;20(7):754-61. doi: 10.1038/ejhg.2012.6. Epub 2012 Feb 8. (http://www.ncbi.nlm.nih.gov/pubmed/22317977?dopt=Abstract)
  • Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS. Report and abstracts of the sixth international workshop on human chromosome 1 mapping 2000. Iowa City, Iowa, USA. 30 September-3 October 2000. Cytogenet Cell Genet. 2001;92(1-2):23-41. (http://www.ncbi.nlm.nih.gov/pubmed/11306795?dopt=Abstract)
  • Shaffer LG, Heilstedt HA. Terminal deletion of 1p36. Lancet. 2001 Dec;358 Suppl:S9. (http://www.ncbi.nlm.nih.gov/pubmed/11784558?dopt=Abstract)
  • White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM, Brodeur GM. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene. 2005 Apr 14;24(16):2684-94. (http://www.ncbi.nlm.nih.gov/pubmed/15829979?dopt=Abstract)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

 
Reviewed: October 2012
Published: August 18, 2014